Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma

BACKGROUND AND AIMS: In this pilot study, we assessed the safety and tolerability of combining sorafenib with (90)Y radioembolization for the treatment of unresectable hepatocellular carcinoma (hcc). METHODS: The study, conducted prospectively during 2009–2012, included eligible patients with unrese...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Salman, A., Simoneau, E., Hassanain, M., Chaudhury, P., Boucher, L.M., Valenti, D., Cabrera, T., Nudo, C., Metrakos, P.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5081020/
https://ncbi.nlm.nih.gov/pubmed/27803608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.2827
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados